Home
Kevin D. Freeman, Director: Galectin Therapeutics GALT Buy · Filed 24/12/26
Trade details
- Type
- Insider buy
- Amount
- $8,100
- Shares · price
- 10,000 sh · $0.81 a share
- Held after
- 44,769 sh
- Person
- Kevin D. FreemanDirector
- Trade date
- 24/12/24
- Filed
- 24/12/26
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 4 insiders
- Holding change
- +28.8%
Galectin Therapeutics trades, last 26 weeks
What else happened in Galectin Therapeutics around then
Filed or reported within 30 days of the trade day · 24/11/24~25/01/23Kevin D. Freeman's recent trades
- Kevin D. Freeman
BuyGalectin Therapeutics
BuyGalectin Therapeutics
GALT
$19.5K
5,500 sh
$19.5K
Filed 25/12/23
Traded 25/12/23
- Kevin D. Freeman
Buy10b5-1 planGalectin Therapeutics
Buy10b5-1 planGalectin Therapeutics
GALT
$19.5K
5,500 sh
$19.5K
Filed 25/12/23
Traded 25/12/23
- Kevin D. Freeman
Buy10b5-1 planGalectin Therapeutics
Buy10b5-1 planGalectin Therapeutics
GALT
$19.5K
5,500 sh
$19.5K
Filed 25/12/23
Traded 25/12/23
- Kevin D. Freeman
BuyGalectin Therapeutics
BuyGalectin Therapeutics
GALT
$14.5K
5,000 sh
$14.5K
Filed 25/07/18
Traded 25/07/17
- Kevin D. Freeman
BuyGalectin Therapeutics
BuyGalectin Therapeutics
GALT
$3,432
1,300 sh
$3,432
Filed 24/10/17
Traded 24/10/17